Intrathecal morphine infusion for chronic non-malignant pain: A multiple center retrospective survey

Neuromodulation

Volumn 7, Issue 4, 2004, Pages 249-259

  Njee, Theodore B ^a   Irthum, Bernard ^b   Roussel, Philippe ^a   Peragut, Jean Claude ^a  

^a TIMONE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Chronic benign pain; Intrathecal morphine; Noncancer pain; Opioids

Indexed keywords

MORPHINE;

ADULT; AGED; AMENORRHEA; BOLUS INJECTION; CATHETER; CHRONIC PAIN; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONSTIPATION; CONTINUOUS INFUSION; DRUG INFUSION; FEMALE; HUMAN; INFUSION PUMP; ISCHIALGIA; LIBIDO DISORDER; LOW BACK PAIN; MALE; MULTICENTER STUDY; NEUROPATHIC PAIN; NIGHTMARE; NOCICEPTION; PAIN; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PRURITUS; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING; WEIGHT GAIN;

EID: 8544239406     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1094-7159.2004.04210.x     Document Type: Review

References (29)

1. Auld AW, Maki-Joleka A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine 1985;10:777-781.
2. Kanoff RB. Intraspinal delivery of opiates by an implantable programmable pump in patients with chronic, intractable pain of non-malignant origin. JAOA 1994;94:487-493.
3. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective multicenter study. J Pain Symptom Manage 1996;11:77-80.
4. Winkelmüller M, Winkelmüller W. Long term effects of continuous intrathecal opioid treatment in chronic pain of non-malignant etiology. J Neurosurg 1996;85:458-467.
5. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic non-malignant pain. Neurosurg 1999;44:289-301.
6. Wang JK, Naus LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979;50:149-151.
7. Behar M, Magora F, Olshwang D, Davidson JT. Epidural morphine in treatment of pain. Lancet 1979;1:527-529.
8. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-186.
9. Bartleson JD. Evidence for and against the use of opioid analgesics for chronic non-malignant low back pain: a review. Pain Med 2002;3:260-271.
10. Suzuki R, Chapman V, Dickenson AH. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain 1999;80:215-228.
11. Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001;5:353-361.
12. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back and leg pain of non cancer origin. South Med J 1996;89:295-300.
13. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of non malignant aetiology long-term benefits and efficacy. Surg Neurol 2001;55:79-86.
14. Jadad AR, Caroll D, Glynn CJ, Moore RA, McQuay HJ. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet 1992;339:1367-1371.
15. Dominguez E, Sahinler B, Bassam D, Day M, Lou L, Racz G, Raj P. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Practice 2002;2:315-325.
16. Gay MLF. Spinal morphine in non-malignant chronic pain: A retrospective study in 39 patients. Neuromodulation 2002;5:150-159.
17. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients recieving intraspinal opioids. J Pain Symptom Manage 1994;9:126-131.
18. Paice JA, Penn RD. Amenorrhea associated with intraspinal morphine. J Pain Symptom Manage 1995; 10:582-583.
19. Doleys DM, Dinoff BL, Page L, Tutak U, Willis KD, Coleton M. Sexual dysfunction and other siode effects of intraspinal opiate use in the management of chronic non-cancer pain. AJPM 1998;8:5-11.
20. Abst R, Verhelst J, Maeyaert J et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-2222.
21. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT. Hypogonadismin patients treated with intrathecal morphine. Clin J Pain 2000;16:251-254.
22. Portenoy RK, Savage SR. Clinical realities and economic considerations: special therapetic issues in intrathecal therapy-tolerance and addiction. J Pain Symptom Manage 1997;14:S27-S35.
23. Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996;85:452-457.
24. Waterman NG, Hughes S, Foster WS. Control of cancer pain by epidural infusion of morphine. Surgery 1991;110:612-616.
25. Stienstra R, Veering BT. Intrathecal drug spread: is it controllable? Reg Anesth Pain Med, 1998;23:347-351; discussion 384-347.
26. Maeyaert J, Kupers RC. Long term intrathecal drug perfusion in the treatment of persistent noncancer pain: a 3-year experience. In: Waldman, SD, Winnie, AP, eds. Interventional Pain Management. Philadelphia, PA: Saunders; 1996: 447-457.
27. Portenoy RK, Foley MK, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypothesis derived from studies of opioid infusions. Pain 1990;43:273-286.
28. Yaksh TL, Harty GJ, Onofrio BM. High doses of spinal morphine produce a non-opiate receptor mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 1986;64:590-597.
29. De Conno F, Caraceni A, Martini C, Spoldi E, Salvetti M, Ventafridda V. Hypemlgesia and myoclonus with infusion of high-dose morphine. Pain 1991;47:337-339.